PTC Therapeutics, Inc. (NASDAQ:PTCT) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET

Company Participants

Ron Aldridge - Senior Director, Investor Relations

Matthew Klein - Chief Executive Officer

Eric Pauwels - Chief Business Officer

Kylie O'Keefe - Chief Commercial Officer

Pierre Gravier - Chief Financial Officer

Conference Call Participants

Kelly Shi - Jefferies

Sami Corwin - William and Blair

Kristen Kluska - Cantor Fitzgerald

David Lebowitz - Citi

Michael Riad - Morgan Stanley

Yihan Li - UBS

Joseph Thome - TD Cowen

Tazeen Ahmad - Bank of America

Paul Choi - Goldman Sachs

Operator

Good day, and thank you for standing by and welcome to the PTC Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded.

I would now like to hand the conference call over to your speaker today, Senior Director of Investor Relations, Ron Aldridge. You may begin.

Ron Aldridge

Good afternoon, and thank you for joining us today to discuss PTC Therapeutics' second quarter 2023 corporate update and financial results.

I'm joined today by our Chief Executive Officer, Dr. Matthew Klein; our Chief Business Officer, Eric Pauwels; our Chief Commercial Officer, Kylie O'Keefe; and our Chief Financial Officer, Pierre Gravier.

Today's call will include forward-looking statements based on our current expectations. Please take a moment to review the slide posted on our Investor Relations website in conjunction with the call, which contains our forward-looking statements.

Our actual results could materially differ from these forward-looking statements, as such statements are subject to risks that can materially and adversely affect our business and results of operations.

For a detailed description of applicable risks and uncertainties, we encourage you to review the company's most recent annual report on Form 10-K filed with the Securities and Exchange Commission, as well as the company's other SEC filings.

We will disclose certain non-GAAP information during this call. Information regarding our use of GAAP to non-GAAP financial measures and a reconciliation of GAAP to non-GAAP are available in today's earnings release.

With that, let me pass the call over to our CEO, Matthew Klein. Matt?

Matthew Klein

Thank you Ron. Good afternoon and thank you for joining the call. I'm pleased to share PTC's second quarter results and our expectations for continued strong performance in 2023.